952 followers
Anti-CD123 chimeric antigen receptor T-cells (CART): an evolving treatment strategy for hematological malignancies, and a potential ace-in-the-hole against antigen-negative relapse. https://t.co/yhfWp7BTjf https://t.co/7zS0DhHTxz
Anti-CD123 chimeric antigen receptor T-cells (CART): an evolving treatment strategy for hematological malignancies, and a potential ace-in-the-hole against antigen-negative relapse. https://t.co/yhfWp7BTjf https://t.co/7zS0DhHTxz
Anti-CD123 chimeric antigen receptor T-cells (CART): an evolving treatment strategy for hematological… https://t.co/mdzrs38UtU #leukemia https://t.co/4Yq6s2yywy